|
|
||||||||
a
a Department of Experimental Pathology and Oncology, University of Florence, Florence, Italy;
b Department of Hematology, A.O. Careggi, Florence, Italy;
c Institute for Medical Research, Belgrade, Yugoslavia;
d Laboratory of Experimental Hematology, University of Limoges, Limoges, France
Key Words. HPP-CFC • IL-3 • G-CSF • In vitro • Mouse • Bone marrow
Dr. Persio Dello Sbarba, Dipartimento di Patologia e Oncologia Sperimentali, Università di Firenze, viale G.B. Morgagni 50, I-50134 Florence, Italy.
Murine bone marrow (BM) cells were cultured in semisolid medium
containing interleukin 3 (IL-3) and high doses of G-CSF. Colonies were
counted twice, at day 7 and day 14, and the number of
granulocyte/macrophage colony-forming units (CFU-GM) accurately
estimated by the subtraction of day-14 from day-7 colonies, based on
the principle that colonies detectable at day 7 and persisting beyond
day 14 are generated by significantly more immature progenitors. The
frequency of colonies relative to their size was determined and used
to define subsets of high proliferative potential colony-forming cells
(HPP-CFC). Two main groups of HPP-CFC were considered: those
generating colonies of 0.6-1.8 mm of diameter or larger than 1.8
mm. The characterization of these groups showed that they correspond
to different functional subsets of HPP-CFC. The replating ability of
colonies was estimated. The percentage of clonogenic progenitors in
the S phase of cell cycle was measured by cytosine arabinoside suicide
assay. The sensitivity of colonies to 5-fluorouracil (5-FU) in vitro
was determined and their survival after an in vivo treatment with 5-FU
compared with that of colony-forming units in spleen (CFU-S). This
technique allowed identification of: A) CFU-GM; B) relatively mature
HPP-CFC, probably corresponding to CFU-S day12; C) more primitive
HPP-CFC, relatively resistant to 5-FU in vivo and closely
corresponding to CFU-S day 14, and D) very primitive HPP-CFC,
resistant to 5-FU in vitro. This simple, rapid, and versatile method
allows the detection of a broad range of hematopoietic progenitors in
murine BM, from committed progenitors to largely quiescent, primitive
stem cells, as well as the evaluation of the progenitors'
self-renewal and proliferative potential. Stem Cells
1999;17:219-225
This article has been cited by other articles:
![]() |
F. R. Santoni de Sio, P. Cascio, A. Zingale, M. Gasparini, and L. Naldini Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction Blood, June 1, 2006; 107(11): 4257 - 4265. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
